An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Investigational Drug Acquiring Popularity Online
The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Express Worries
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of uncertain source.
Several professionals said the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking penalties, prosecution or imprisonment.
Platform Reaction and Material Elimination
According to TikTok, the service has removed problematic content and prohibited associated keywords and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also found groups with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, filled with images of weight loss, positive testimonials and step-by-step guides for preparing or administering at home.
Within minutes of joining one group, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or past usage.
Item Details and Pricing
Inside these communities, posts display dark colored packages with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they can’t verify. Although the research behind this drug is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has already encountered individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to potentially serious medical dangers”.
